HB TempCon is a subsidiary company of Qingdao Haier Biomedical CO., LTD, established in December 2021 and granted the 6U IATA code in February 2022.
Recently, HB TempCon's Active Temperature Controlled RKN Container carried by the CZ463 cargo flight reached Frankfurt Airport, Germany from Shanghai Pudong Airport, China. The successful launch of the "PVG-FRA" international route is another breakthrough of HB TempCon after successfully completing the flight mission of its regional route "PVG-TPE” which means that HB TempCon has officially stepped into the international stage.
During the PVG-FRA flight, HB TempCon's RKN container was highly praised by partners and customers for its easy operation and stable temperature performance.
With the rapid development of biopharmaceutical, high-end chemical, and electronic technology-related industries, the global market demand for high-value temperature-sensitive materials is growing rapidly, and aviation temperature-controlled logistics has entered a rapid rise. According to IATA statistics, global airfreight biologics grew by 40% between 2019 and 2021. According to Global Biologics Market forecast data, the global biologics market is expected to grow from USD 268.5 billion in 2021 to USD 420.6 billion by 2025, at a CAGR of 12%. In this case, HB TempCon brings new energy to the field of aviation active temperature control.
Currently, HB TempCon's Route Network has covered several major airports worldwide such as : ORD, LAX, FRA, AMS, and PVG. It will continue to improve the layout of the airline, operation, and maintenance network and strive to provide users with full-scenario and whole-process Supply Chain Temperature Control Solutions in the whole temperature range.
Jeff Shen
Marketing Director
